Agios Pharmaceuticals SG&A Expense (TTM) Analysis

Agios Pharmaceuticals Inc (AGIO)

43.11 -0.50 (-1.15%) USD | NASDAQ | Jun 28, 16:00

43.03 -0.08 (-0.19%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	122.55M
December 31, 2023	119.90M
September 30, 2023	117.37M
June 30, 2023	120.67M
March 31, 2023	118.52M
December 31, 2022	121.67M
September 30, 2022	120.43M
June 30, 2022	118.46M
March 31, 2022	119.41M
December 31, 2021	121.44M
September 30, 2021	115.83M
June 30, 2021	117.02M
March 31, 2021	116.98M
December 31, 2020	115.11M
September 30, 2020	94.00M
June 30, 2020	98.68M
March 31, 2020	101.89M
December 31, 2019	102.01M
September 30, 2019	129.06M
June 30, 2019	127.14M
March 31, 2019	121.39M
December 31, 2018	114.14M
September 30, 2018	105.00M

Date	Value
June 30, 2018	91.35M
March 31, 2018	80.85M
December 31, 2017	71.12M
September 30, 2017	63.79M
June 30, 2017	58.19M
March 31, 2017	54.70M
December 31, 2016	50.71M
September 30, 2016	45.52M
June 30, 2016	43.59M
March 31, 2016	39.88M
December 31, 2015	35.99M
September 30, 2015	32.31M
June 30, 2015	27.55M
March 31, 2015	22.79M
December 31, 2014	19.12M
September 30, 2014	16.33M
June 30, 2014	13.69M
March 31, 2014	11.36M
December 31, 2013	9.929M
September 30, 2013	7.776M
June 30, 2013	6.822M
March 31, 2013	6.934M
December 31, 2012	7.063M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

94.00M

Minimum

Sep 2020

129.06M

Maximum

Sep 2019

115.32M

Average

118.46M

Median

Jun 2022

SG&A Expense (TTM) Benchmarks